Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Respiratory Inhalers Companies

Respiratory inhaler companies develop and manufacture devices that deliver medications directly to the lungs, helping individuals with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) manage their symptoms. These companies play a crucial role in providing effective treatments and improving the quality of life for people with respiratory conditions.

*Disclaimer: List of key companies in no particular orderLatest Respiratory inhaler Companies Update

May 2023: To standardize and uniformly manage patients with severe asthma, the biopharmaceutical giant AstraZeneca India will create five Centers of Excellence in the cities of New Delhi, Ahmedabad, Goa, and Kochi. According to a press release, these facilities will "act as a hub for the treatment and management of severe asthma patients" and "assist emerging severe asthma centers" in their efforts to "identify and treat severe asthma patients in a systematic and guidelines-based manner.

July 2023: BreynaTM (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. FDA, was released by the global healthcare company Viatris Inc. and the specialty pharmaceutical company Kindeva Drug Delivery L.P. Breyna is a combination medication and inhaler that is now available in two different dose strengths: 80 mcg/4.5 mcg and 160 mcg/4.5 mcg, respectively, and is recommended for use by patients with asthma or chronic obstructive pulmonary disease (COPD).

July 2023: Teva introduced their first digitally-enabled inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in the United Kingdom in July 2023. The inhaled corticosteroid budesonide and long-acting beta agonist formoterol are delivered via the GoResp Digihaler, which incorporates sensors to track and record a patient's usage and efficacy. With a simple Bluetooth connection, the findings may be sent to a smartphone and seen there or sent to a doctor. Teva claims their new integrated inhaler is the first to have sensors that can detect and record objective data on the inhaler user, such as inspiratory flow measurements that may be used to categorize a patient's respiratory symptoms.

List of Respiratory inhaler Key companies in the market

Teva Pharmaceutical Industries Ltd.

AstraZeneca

PARI Medical Holding

Beximco Pharmaceuticals Ltd.

OMRON Healthcare Europe

Boehringer Ingelheim GmbH

Merck & Co Inc.

GlaxoSmithKline plc

Cipla Ltd.

Koninklijke Philips N.V

Respiratory Inhalers Market Highlights:

Respiratory Inhalers Market Size

Respiratory Inhalers Market Trends

Respiratory Inhalers Market Analysis

Respiratory Inhalers Market Share

Respiratory Inhalers Market Highlights:

Respiratory Inhalers Market Trends

Respiratory Inhalers Market Analysis

Respiratory Inhalers Market Share

Respiratory Inhalers Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.